Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Expert Review of Vaccines|July 14, 2010
DNA vaccines for targeting bacterial infectionsMariana Ingolotti, Omkar Kawalekar, Devon J Shedlock, et al.Current Drug Delivery|November 25, 2005
HIV-1 Vpr: enhancing sensitivity of tumors to apoptosisKaruppiah Muthumani, Andrew Y Choo, Daniel S Hwang, et al.DNA and Cell Biology|October 25, 2002
The HIV-1 accessory gene vpr can inhibit antigen-specific immune functionKaruppiah Muthumani, Daniel S Hwang, Nathaniel S Dayes, et al.Current Opinion in Virology|March 24, 2012
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivoNatalie A Hutnick, Devin J F Myles, Chaoran Billie Bian, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2006
Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporationAndrea N McCray, Kenneth E Ugen, Karuppiah Muthumani, et al.Apoptosis : an International Journal on Programmed Cell Death|July 16, 2008
HIV-1 viral genes and mitochondrial apoptosisDevon J Shedlock, Daniel Hwang, Andy Y Choo, et al.Journal of Vascular Surgery|July 16, 2013
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemiaGeoffrey O Ouma, Eduardo Rodriguez, Karuppiah Muthumani, et al.International Immunology|December 22, 2004
HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitroKaruppiah Muthumani, Daniel S Hwang, Andrew Y Choo, et al.The Journal of Biological Chemistry|July 4, 2002
HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cellsKaruppiah Muthumani, Daniel S Hwang, Brijal M Desai, et al.Plos One|August 25, 2015
REDD1 Is Essential for Optimal T Cell Proliferation and SurvivalEmma L Reuschel, JiangFang Wang, Debra K Shivers, et al.Pageof 5